[
    [
        {
            "time": "",
            "original_text": "医药CRO系列报告之康龙化成（300759）深度报告：立足实验室化学，后端业务拓展潜力巨大",
            "features": {
                "keywords": [
                    "医药",
                    "CRO",
                    "康龙化成",
                    "实验室化学",
                    "后端业务",
                    "潜力"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CRO行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药CRO系列报告之康龙化成（300759）深度报告：立足实验室化学，后端业务拓展潜力巨大",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 1,
                "Headline_Structure": 6,
                "Source_Recency": 2
            }
        }
    ]
]